190792-74-6

Basic information

• Product Name: (3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine
• Synonyms: (3s,4s)-n-boc-3-amino-4-hydroxypyrrolidine;1-Pyrrolidinecarboxylicacid,3-amino-4-hydroxy-,1,1-dimethylethylester,(3S,4S)-(9CI);(3S,4S)-3-Amino-4-hydroxypyrrolidine-1-carboxylic acid tert-butyl ester;(3S,4S)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate;1-Boc-(3S,4S)-3-aMino-4-hydroxypyrrolidine;(3S,4S)-4-aMino-1-N-tert-butyloxycarbonyl-3-hydroxypyrrolidine;Trans-(3S,4S)-1-Boc-3-aMino-4-hydroxypyrrolidine;tert-butyl (3S,4S)-3-amino-4-hydroxypyrrolidine-1-carboxylate
• CAS NO: 190792-74-6
• Molecular Formula: C₉H₁₈N₂O₃
• Molecular Weight: 202.25
• Product Categories: AMINOACID
• Mol File: 190792-74-6.mol

Chemical Properties

• Boiling Point: 308.762 °C at 760 mmHg
• Flash Point: 140.535 °C
• Appearance: /
• Density: 1.179
• Storage Temp.: 2-8°C(protect from light)
• PKA: 14.36±0.40(Predicted)
• CAS DataBase Reference: (3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine(190792-74-6)
• EPA Substance Registry System: (3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine(190792-74-6)

Safety Data

• Hazardous Substances Data: 190792-74-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Development:
(3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine is used as an intermediate compound in the synthesis of various pharmaceuticals. Its unique stereochemistry and the presence of the Boc protecting group make it a valuable building block for the development of new drugs.
Used in Scientific Research:
In the field of scientific research, (3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine serves as a key compound for studying the properties and reactivity of Pyrrolidine derivatives. Its use in research helps in understanding the potential applications and limitations of this class of compounds in various chemical and biological processes.
Used in Chemical Synthesis:
(3S,4S)-N-Boc-3-amino-4-hydroxypyrrolidine is used as a protected amino alcohol in the synthesis of complex organic molecules. The Boc protecting group allows for selective reactions to occur at other sites on the molecule, while the amino and hydroxy groups remain protected from unwanted side reactions. This makes it a useful tool in the synthesis of a wide range of chemical products.

Upstream product

• 252574-03-1 (3S,4S)-1-tert-butoxycarbonyl-trans-3-benzylamino-4-hydroxypyrrolidine 
• 4248-19-5 tert-butyl carbazate 
• 114214-49-2 1-tert-butoxycarbonyl-3,4-epoxypyrrolidine 
• 1202067-33-1 (3S,4S)-3-azido-4-(trimethylsilanyloxy)pyrrolidine-1-carboxylic acid tert-butyl ester 
• 926913-20-4 (3R,4S)-1-N-tert-butyloxycarbonyl-4-(4,4'-dimethoxytrityloxy)-3-mesyloxy-pyrrolidine 
• 190792-84-8 (3S,4S)-3-azido-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 252574-02-0 (±)-trans-tert-butyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate 
• 73286-70-1 N-(tert-butoxycarbonyl)-3-pyrroline 
• 24424-99-5 di-tert-butyl dicarbonate 
• 203434-45-1 (±)-tert-butyl 3-azido-4-hydroxypyrrolidine-1-carboxylate 
• 183184-52-3 1-((3S,4S)-3-azido-4-hydroxypyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one 
• 164931-85-5 meso-N-trifluoroacetyl-3-pyrroline oxide 

Downstream Products

• 1333414-02-0 (3S,4S)-tert-butyl 3-(tert-butyldiphenylsilyloxy)-4-(trifluoromethylsulfonamido)pyrrolidine-1-carboxylate 
• 859213-33-5 (3S,4S)-tert-butyl 3-(dimethyl amino)-4-hydroxypyrrolidine-1-carboxylate 
• 1202067-41-1 (3aS,6aR)-2-phenyl-3a,4,6,6a-tetrahydropyrrolo[3,4-d]oxazole-5-carboxylic acid tert-butyl ester 
• 1215210-04-0 (3S,4S)-3-amino-4-hydroxypyrrolidine dihydrochloride 
• 1202067-40-0 (3S,4S)-3-benzoylamino-4-hydroxypyrrolidine-1-carboxylic acid tert-butyl ester 
• 138026-97-8 (3R,4S)-4-amino-1-N-tert-butyloxycarbonyl-3-hydroxypyrrolidine 

Relevant articles and documents

N -phosphonocarbonylpyrrolidine derivatives of guanine: A new class of Bi-substrate inhibitors of human purine nucleoside phosphorylase

A complete series of pyrrolidine nucleotides, (3R)- and (3S)-3-(guanin-9-yl)pyrrolidin-1-N-ylcarbonylphosphonic acids and (3S,4R)-, (3R,4S)-, (3S,4S)-, and (3R,4R)-4-(guanin-9-yl)-3-hydroxypyrrolidin-1-N- ylcarbonylphosphonic acids, were synthesized and e

Highly active organocatalysts for asymmetric anti-mannich reactions

Lighten the load! A family of enantiopure 4-oxy-substituted 3-aminopyrrolidines arising from the enantioselective ring-opening of meso-3-pyrroline oxide have been developed as catalysts for the asymmetric, anti-selective Mannich reaction (see scheme; PMP=

THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS

A series of thieno[2,3-6]pyridine derivatives, attached at the 2-position to a substituted anilino moiety, which are substituted in the 3-position by a carbonyl group linked to a pyrrolidin-1-yl ring which in turn forms part of a heteroatom-containing fus

Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit

Starting from a hit identified by focused screening, 3-aminopyrrolidine factor Xa inhibitors were designed. The binding mode as determined by X-ray structural analysis as well as the pharmacokinetic behaviour of selected compounds is discussed.

MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE

The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

Cyclic amines

The invention is concerned with cyclic amines of formula (I) wherein X1 to X3, Y1 to Y3, R1′, R1″ and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit coagulation factor Xa and can be used as medicaments and for treating diseases associated with coagulation factor Xa.

Cathepsin cysteine protease inhibitors

This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of Cathepsins K and L. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily

The present invention relates to compounds and pharmaceutical compositions which inhibit proteases, such as cysteine proteases. In particular, the present invention relates to compounds and pharmaceutical compositions which inhibit cysteine proteases of the papain superfamily. The compounds and pharmaceutical compositions of the present invention are useful for treating diseases, particularly parasitic diseases, which are mediated by such proteases. In particular, the present invention relates to a method of treating malaria by inhibiting the cysteine protease falcipain.

Practical synthesis of (3S,4S)-3-methoxy-4-methylaminopyrrolidine

Three synthetic methods for the preparation of (3S,4S)-3-methoxy-4-methylaminopyrrolidine, an important intermediate in the synthesis of the novel quinolone antitumur agent, AG-7352, have been developed. By one route, an efficient and large-scale preparation of the chiral pyrrolidine could be achieved through resolution of (±)-1-Boc-3-benzylamino-4-hydroxypyrrolidine, which is prepared from either 3-pyrroline or 1,4-dichloro-2-butene.